IN THIS ISSUE

Richard Mark Kirkner
Lax regulations and fee-for-service payment make an irresistible mix for physician conflicts. Are ACOs the answer?
Carol Milano
Medco’s ‘gaps in care’ approach saves $900 million by targeting 15 chronic conditions
Lola Butcher
This is no one-size-fits-all solution, as insurers across the country tailor efforts for specific markets
Michael Graf, MS
A widely available but underused molecular genetic blood test has proved to be accurate over 98% of the time and costs less than $400
Editor's Memo
John Marcille
Viewpoint
Jeff Kang, MD
In a system where people will soon shop for their benefits on exchanges, plans that offer the best customer service will have the edge
Medication Management
Thomas Reinke
Health plans are expanding MTM — once considered a Part D mainstay — to their commercial businesses.
Evidence Review
A summary of the ECRI Institute’s Emerging Technology Evidence Report
Legislation & Regulation
John Carroll
The need for health plans to cut administrative costs is hammering insurance brokers. Is this another instance of the law of unintended consequences?
Tomorrow’s Medicine
Thomas Morrow, MD
Brilinta’s price will be a significant factor in coverage decisions when Plavix goes off patent in May 2012
Plan Watch
Frank Diamond
If UnitedHealth Group’s effort to buy a large physician group proves successful, clinical execs will have even more oversight
News and Commentary
News and Commentary
News and Commentary